news + headlines
In honor of Global Female Condom Day, it’s time to clear up a few myths still hovering around the elusive female condom.
Sexual shame creates a breeding ground for HIV within the gay community, says activist Hussain Turk.
Truvada should be covered as a public health expense, says HIV prevention advocate
Researchers have found a new site on HIV’s surface that is vulnerable to a powerful antibody, a discovery that could lead to novel developments in the treatment, prevention and vaccine fields.
Treatment with pre-exposure prophylaxis (PrEP) does not involve a significant risk of HIV drug resistance should seroconversion occur, results from the iPrEx study published in the online edition of the Journal of Infectious Diseases demonstrate. The only cases of drug resistance among people who had taken PrEP involved individuals with unrecognised acute HIV infection when they started therapy.
This report from the UK hails extraordinary success of HIV services but highlights need to adapt to an ageing population.
According to the Public Health Agency of Canada, Saskatchewan’s HIV rate is double the national average and Saskatoon has the highest HIV rate in the country.